H
H E Windschitl
Researcher at Mayo Clinic
Publications - 13
Citations - 1161
H E Windschitl is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Hormonal therapy & Tamoxifen. The author has an hindex of 12, co-authored 13 publications receiving 1148 citations.
Papers
More filters
Journal ArticleDOI
A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma: Fluorouracil vs Fluorouracil and Doxorubicin vs Fluorouracil, Doxorubicin, and Mitomycin
Stephen A. Cullinan,Charles G. Moertel,Thomas R. Fleming,Joseph Rubin,James E. Krook,L K Everson,H E Windschitl,Donald I. Twito,Robert F. Marschke,John F. Foley,Del M. Pfeifle,John F. Barlow +11 more
TL;DR: Because of a failure to produce improved survival or palliation, unrewarded toxicity, and excessive cost, neither the FA nor FAM regimen can be recommended for the treatment of advanced pancreatic or gastric cancer.
Journal ArticleDOI
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer
JN Ingle,James E. Krook,Green Sj,T P Kubista,L K Everson,David L. Ahmann,M N Chang,Harry F. Bisel,H E Windschitl,D I Twito +9 more
TL;DR: There was no overall disadvantage to the use of tamoxifen as opposed to oophorectomy as initial hormonal therapy, and a failure to respond to tamoxIFen did not preclude a response to subsequent oophoractomy.
Journal ArticleDOI
Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.
Charles L. Loprinzi,S. Abu-Ghazaleh,Jeff A. Sloan,C. vanHaelst-Pisani,A. M. Hammer,Kendrith M. Rowland,Mark E. Law,H E Windschitl,Judith S. Kaur,Neil M. Ellison +9 more
TL;DR: Both Replens and the placebo appear to substantially ameliorate vaginal dryness and dyspareunia in breast cancer survivors.
Journal ArticleDOI
Adjuvant Therapy for Resectable Colorectal Carcinoma With Fluorouracil Administered by Portal Vein Infusion: A Study of the Mayo Clinic and the North Central Cancer Treatment Group
Robert W. Beart,Charles G. Moertel,Harry S. Wieand,John E. Leigh,H E Windschitl,Jonathan A. van Heerden,Robert J. Fitzgibbons,Bruce G. Wolff +7 more
TL;DR: The same lack of treatment effect is seen in both the stage B and C subsets of resected Dukes' stage B2 or C colorectal cancer.
Journal ArticleDOI
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis
James N. Ingle,Harry J. Long,Donald I. Twito,Daniel J. Schaid,Stephen A. Cullinan,James G. Gerstner,James E. Krook,James A. Mailliard,Loren K. Tschetter,H E Windschitl,Ralph Levitt,Delano M. Pfeifle +11 more
TL;DR: The data suggest that there is a substantive therapeutic advantage for TAM plus FLU over TAM alone in elderly women with ER of 10 fmol or greater, and require confirmation in a prospective randomized trial.